Logo American Journal of Case Reports

Call: 1.631.629.4328
Mon-Fri 10 am - 2 pm EST

Contact Us

Logo American Journal of Case Reports Logo American Journal of Case Reports Logo American Journal of Case Reports

16 May 2018: Articles  Japan

Reduction of Blood Pressure Following After Renal Artery Adventitia Stripping During Total Nephroureterectomy: Potential Effect of Renal Sympathetic Denervation

Unusual or unexpected effect of treatment

Keisuke Okamura DEF 1*, Shunsuke Satou DEF 1,2, Keita Setojima DE 2, Shinjiro Shono DE 3, Shigero Miyajima DE 4, Tatsu Ishii DE 4, Kazuyuki Shirai DE 1, Hidenori Urata DE 1

DOI: 10.12659/AJCR.908891

Am J Case Rep 2018; 19:567-572

0 Comments

Abstract

BACKGROUND: Catheter-based renal sympathetic denervation has been reported to be effective for treatment resistance hypertension in Australia and Europe. However, in the blinded SYMPLICITY HTN-3 trial, renal denervation did not achieve a significant decrease in blood pressure (BP) in comparison to sham controls. There have been various discussions on the factors that influenced this result.

CASE REPORT: Two men on antihypertensive therapy underwent unilateral radical nephroureterectomy for cancer of the renal pelvis. When the renal artery adventitia was stripped and cauterized just before renal artery ligation, the measured BP of the 2 men increased after stripping adventitia and decreased gradually after cauterization of the renal artery. This was presumably due to removal of renal artery sympathetic nerves, similar to the mechanism of catheter-based renal sympathetic denervation, although anesthesia, fluid infusion, and/or mesenteric traction may have had an influence.

CONCLUSIONS: A similar strategy involving thoracolumbar sympathectomy was reported about 50 years ago. The clinically significant blood pressure reduction in these patients suggests renal denervation is effective.

Keywords: Hypertension, Nephrectomy, Sympathectomy

Background

Hypertension is a very common lifestyle-related disease, and it is estimated that approximately 43 million persons have hypertension in Japan [1]. The prognosis of resistant hypertension is poor, and its management is difficult. In some patients, acceptable control of the office blood pressure (BP) and/or home BP cannot be achieved despite the use of multiple antihypertensive agents. In Australia and Europe, it has been reported that catheter-based renal sympathetic denervation [2] is effective for resistant hypertension [3–5]. As a mechanism, suppression of sodium absorption in the renal tubule and sympathetic hyperactivity to the whole body were considered. SYMPLICITY HTN-3 renal denervation trial (SH-3) randomized patients into renal denervation or sham procedure [6]. Catheter-based renal denervation was performed according to the Instructions for Use of the Symplicity™ RDN system following renal angiography to confirm suitable anatomy. However, this controlled trial did not demonstrate significant reduction of BP with renal denervation compared to sham treatment [6], although there has been considerable discussion of this outcome [7].

Cancer of the renal pelvis is treated by nephroureterectomy. For intraoperative management of the renal artery, the peri-arterial tissues containing renal sympathetic nerves [8] are stripped to expose the vessel and it is ligated after cauterization. However, there have been no reports about the detailed changes of BP during the process of stripping the renal artery adventitia. Based on the expected effect of renal denervation, we hypothesized that careful intraoperative monitoring might be able to detect a decrease of BP when the peri-arterial tissues are carefully stripped, and the renal artery is cauterized. Accordingly, we performed such monitoring in 2 patients undergoing nephroureterectomy.

Case Reports

CASE 1:

An 85-year-old male underwent curative surgery for left renal pelvic cancer. His past history included hypertension and he was taking an angiotensin II receptor blocker. But his BP was not under control. Laparoscopic left nephroureterectomy was performed under general anesthesia, with the adventitia around the renal artery (which probably contains renal sympathetic nerves) being stripped off and cauterized carefully just before renal artery ligation (Figure 1). The noninvasively measured BP increased after the renal artery adventitia was stripped, while the pulse rate was unchanged. Then BP decreased gradually after cauterization of the renal artery, although the pulse rate still showed no change (Figure 2). The noninvasive BP increased from 93/63 mmHg to 120/70 mmHg after stripping of the renal artery adventitia, while the pulse rate changed from 62 bpm to 64 bpm. After cauterization of the adventitia, the BP gradually decreased from 98/61 mmHg to 78/52 mmHg and the pulse rate changed minimally from 62 bpm to 63 bpm.

CASE 2:

An 89-year-old male with resistant hypertension was taking 3 antihypertensive agents (a calcium channel blocker, an angiotensin II receptor antagonist, and a diuretic). He underwent open right nephroureterectomy under general anesthesia for renal pelvic cancer, with the adventitia around the renal artery being stripped off and cauterized as in Case 1. The invasively measured BP increased after stripping of the renal artery adventitia and then decreased gradually again after cauterization, as was noted in Case 1 (Figure 3). The invasive BP increased from 121/50 mmHg to 133/53 mmHg after stripping of the renal artery adventitia, while the pulse rate changed minimally from 75 bpm to 76 bpm. After cauterization of the adventitia, the BP gradually decreased from 133/53 mmHg to 98/47 mmHg and the pulse rate changed from 74 bpm to 71 bpm.

Discussion

Both patient cases reported here underwent unilateral radical nephroureterectomy for renal pelvic cancer, during which the renal artery adventitia was stripped off and cauterized. Monitoring revealed that the BP initially increased during these procedures and subsequently showed a gradual decrease. It is possible that these changes of BP were related to alteration of renal sympathetic activity when the peri-arterial tissues were stripped off and cauterized. Although there were fewer nerves surrounding the renal artery in the distal segments compared with the proximal and middle segments, the mean distance from renal artery lumen to nerve location is least in the distal segments compared with the proximal and middle segments [9]. It was possible that all these nerves had been removed by stripping and cauterizing.

The autonomic nervous system (sympathetic and parasympathetic systems) regulates BP in coordination with the reninangiotensin system. Sympathetic activity is controlled by the rostral ventrolateral medulla. Direct evaluation of the sympathetic nerve system in humans can be performed by recording muscle sympathetic nerve activity and isotopic assessment of norepinephrine spillover [10], but these are invasive methods. Analysis of heart rate variability on the ECG has been used for noninvasive evaluation of sympathetic activity following renal denervation, but this method cannot be employed during surgery. Thus, the BP changes noted in our 2 patients were considered to be caused by interruption of the afferent and efferent renal sympathetic nerve pathways, but it is difficult to prove that an effect on sympathetic nerves was involved.

When the renal artery was stimulated by stripping of the peri-arterial tissues, the BP increased transiently in both patients. An increase of renal sympathetic activity leads to increased renin secretion, enhanced sodium reabsorption, and elevation of BP as a result of decreased renal blood flow [11–13]. In addition, intraoperative maneuvers involving the renal artery might have promoted renin secretion by reducing blood flow to the kidney, thus increasing BP. Furthermore, electrical stimulation of the renal artery causes an increase of local renal arterial pressure [14], suggesting that direct renal artery stimulation might have increased autonomic activity and led to elevation of BP.

The BP decreased after the tissues around the renal artery had been stripped and cauterized, possibly because stimulation by the procedure had ceased. However, the base BP was lower after the procedure than before surgery and this suggests that the decline was not only due to the end of direct renal artery stimulation. In animal studies, unilateral activation of the renal sympathetic nervous system can increase systemic sympathetic activity and unilateral renal sympathetic denervation may not decrease the systemic BP, so it is considered that bilateral renal denervation is required to reduce BP [14]. However, catheter-based denervation is conducted inside the renal artery lumen, and it is possible that removal of sympathetic nerves from the peri-arterial tissues may have a different effect. In the present 2 cases, the renal artery adventitia was macroscopically stripped and cauterized, which may have achieved complete denervation. Accordingly, if complete renal denervation could be achieved by a catheter-based procedure, unilateral treatment might reduce BP.

Other possible causes of BP changes during surgery include the use of vasopressors, anesthesia, fluid infusion, mesenteric traction, and dehydration. In the present case study of 2 patients, additional administration of vasopressors and anesthetics or fluid infusion were not conducted at the time of stripping and cauterization of the tissues around the renal artery. There was also no evidence of mesenteric traction syndrome, which is characterized by facial flushing, tachycardia, and low BP. Accordingly, the potential influence of these factors on the changes of BP was ruled out.

Evaporation may induce dehydration when organs are exposed to air intraoperatively, but the duration of surgery was too short for this to be likely to influence BP in our patients.

It appeared in both cases that the decrease in BP after cauterization was transient followed by some BP recovery to close to baseline. Other sympathetic nervous system and renin angiotensin system might be supplemented.

The concept of renal denervation for treatment of hypertension is not new. In the 1950s, surgical renal denervation was advocated for management of hypertension [15], and sympathectomy [16] was conducted. Of course, this was too invasive for routine antihypertensive treatment. Moreover, those studies [15,16] (as with recent clinical trials) did not involve careful evaluation of the BP response such as by ambulatory monitoring or assessment of the effect of sham surgery, so it is unclear whether sympathetic denervation resulted in a significant decrease of BP.

Recently, a clinical study of ultrasound-based renal denervation in patients with resistant hypertension was initiated in Japan and Korea (REQUIRE; ClinicalTrials.gov Identifier: NCT02918305). The ultrasound system used in the study (Paradise system) can cauterize the entire vessel lumen, after which the vessel is cooled by a balloon to avoid excessive arterial wall heating and tissue damage [17]. Prospective open label clinical studies have demonstrated the safety and efficacy of renal denervation in patients with resistant hypertension [18,19]. Moreover, the REDUCE HTN REINFORCE study using the Vessix system (ClinicalTrials.gov Identifier: NCT02392351) and the SPYRAL HTN OFF-MED trial using the Symplicity Spyral catheter [20] have been initiated to assess renal denervation for hypertension.

However, the number of eligible patients enrolled in the REQUIRE trial so far is quite small and patient recruitment is challenging [21]. Based on the results of SH-3 [6], renal denervation is generally seen as being of doubtful value for hypertension and patient enrollment also appears slow in the other studies. In order to complete enrollment in these studies, positive results regarding renal denervation are needed. In this context, the present observations may suggest the clinical significance of renal denervation for decreasing the BP.

In the present two cases, operative findings indicated that the renal artery has thick walls and dense surrounding tissues. Therefore, if intraluminal renal denervation is performed, the nerves outside the renal artery will not be cauterized unless very strong voltage is applied, but this could lead to vascular injury that may result in dissection or stenosis. It is possible that the catheter used in SH-3 might not have cauterized the peri-arterial nerves, which may help to explain the less than significant BP reduction in that study [6]. The Paradise system protects the vessel wall with its cooling balloon and the ultrasound penetrates deeper into the tissue [17,22], so it may achieve more potent BP reduction.

In our patients, we removed the kidney immediately after re-section of the renal artery; nephrectomy involves significant invasion, making it difficult to evaluate the long-term BP lowering effect of renal denervation. In normal rats, it has been reported that afferent renal sympathetic denervation by bilateral rhizotomy inhibited salt sensitive hypertension [23].

After bilateral surgical renal denervation, it would be interesting to investigate whether BP was increased or not after electrical stimulation of the renal artery in accordance with the method of Chinushi et al. [14]. In humans, it is not possible to conduct bilateral surgical RDN to investigate its BP-lowering effect, but the results of further clinical trials of catheter-based renal denervation are awaited.

Conclusions

In the 2 patient cases reported here, reduction of BP might have occurred due to disruption of the sympathetic nerves around the renal artery, a similar mechanism to the antihypertensive effect observed in previous trials of catheter-based renal denervation. Although the findings might have been incidental, the change of BP was clinically significant, and we considered it to represent the effect of renal denervation.

References:

1.. Miura K, Nagai M, Ohkubo T, Epidemiology of hypertension in Japan: Where are we now?: Circ J, 2013; 77; 2226-31, pmid: 23902998

2.. Aronow WS, Fleg JL, Pepine CJ, ACCF/AHA 2011 expert consensus document on hypertension in the elderly: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension: J Am Soc Hypertens, 2011; 5; 259-352, pmid: 21771565

3.. Krum H, Schlaich M, Whitbourn R, Catheter-based renal sympathetic denervation for resistant hypertension: A multicentre safety and proof-of-principle cohort study: Lancet, 2009; 373; 1275-81, pmid: 19332353

4.. , Catheter-based renal sympathetic denervation for resistant hypertension: Durability of blood pressure reduction out to 24 months: Hypertension, 2011; 57; 911-17, pmid: 21403086

5.. Esler MD, Krum H, Sobotka PA, Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial: Lancet, 2010; 376; 1903-9, pmid: 21093036

6.. Bhatt DL, Kandzari DE, O’Neill WW, A controlled trial of renal denervation for resistant hypertension: N Engl J Med, 2014; 370; 1393-401, pmid: 24678939

7.. Kandzari DE, Bhatt DL, Brar S, Predictors of blood pressure response in the SYMPLICITY HTN-3 trial: Eur Heart J, 2015; 36(4); 219-27, pmid: 25400162

8.. Mompeo B, Maranillo E, Garcia-Touchard A, The gross anatomy of the renal sympathetic nerves revisited: Clin Anat, 2016; 29; 660-64, pmid: 27090982

9.. Sakakura K, Ladich E, Cheng Q, Anatomic assessment of sympathetic peri-arterial renal nerves in man: J Am Coll Cardiol, 2014; 64; 635-43, pmid: 25125292

10.. Schlaich MP, Sobotka PA, Krum H, Renal sympathetic-nerve ablation for uncontrolled hypertension: N Engl J Med, 2009; 361; 932-34, pmid: 19710497

11.. DiBona GF, Neural control of the kidney: Past, present, and future: Hypertension, 2003; 41; 621-24, pmid: 12623969

12.. DiBona GF, Physiology in perspective: The wisdom of the body. Neural control of the kidney: Am J Physiol Regul Integr Comp Physiol, 2005; 289; R633-41, pmid: 16105818

13.. Schlaich MP, Schmieder RE, Bakris G, International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertension: J Am Coll Cardiol, 2013; 62; 2031-45, pmid: 24021387

14.. Chinushi M, Izumi D, Iijima K, Blood pressure and autonomic responses to electrical stimulation of the renal arterial nerves before and after ablation of the renal artery: Hypertension, 2013; 61; 450-56, pmid: 23283361

15.. Oldham JB, Denervation of the kidney: Ann R Coll Surg Engl, 1950; 7; 222-45, pmid: 14771775

16.. Newcombe CP, Shucksmith HS, Suffern WS, Sympathectomy for hypertension; Follow-up of 212 patients: Br Med J, 1959; 1; 142-44, pmid: 13618577

17.. Sakakura K, Roth A, Ladich E, Controlled circumferential renal sympathetic denervation with preservation of the renal arterial wall using intraluminal ultrasound: A next-generation approach for treating sympathetic overactivity: EuroIntervention, 2015; 10; 1230-38, pmid: 25349043

18.. Mabin T, Sapoval M, Cabane V, First experience with endovascular ultrasound renal denervation for the treatment of resistant hypertension: EuroIntervention, 2012; 8; 57-61, pmid: 22580249

19.. Daemen J, Van Mieghem N, First-in-man radial access renal denervation with the ReCor Radiance catheter: EuroIntervention, 2015; 10; 1209-12, pmid: 25493912

20.. Sanghvi K, McGrew A, Hegde K, Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications: Am Heart J, 2016; 180; e1-2, pmid: 27659891

21.. Okamura K, Shirai K, Okuda T, The prevalence of Japanese outpatients with hypertension who meet the definition of treatment resistant hypertension and are eligible for enrolment in clinical trials of endovascular ultrasound renal denervation: Intern Med, 2018; 57; 1-12, pmid: 29033430

22.. Pathak A, Coleman L, Roth A, Renal sympathetic nerve denervation using intraluminal ultrasound within a cooling balloon preserves the arterial wall and reduces sympathetic nerve activity: EuroIntervention, 2015; 11; 477-84, pmid: 26298415

23.. Kopp UC, Cicha MZ, Smith LA, Dietary sodium loading increases arterial pressure in afferent renal-denervated rats: Hypertension, 2003; 42; 968-73, pmid: 14568995

In Press

Case report  China

Thrombolytic Therapy After Return of Spontaneous Circulation in Patients With STEMI From Medically Underdev...

Am J Case Rep In Press; DOI: 10.12659/AJCR.949976  

Case report  Greece

Multilevel Laminectomy for Lumbar Spinal Stenosis With Low Back Pain in Achondroplasia: A Case Report

Am J Case Rep In Press; DOI: 10.12659/AJCR.950290  

Case report  Italy

Fractional CO₂ Laser (SCAR3 Scanner) for a Hypertrophic Retracting Cleft Lip Scar: A Case Report

Am J Case Rep In Press; DOI: 10.12659/AJCR.950607  

Case report  Saudi Arabia

Postoperative Corneal Dellen Following PreserFlo MicroShunt: A Case Report

Am J Case Rep In Press; DOI: 10.12659/AJCR.950985  

Most Viewed Current Articles

07 Dec 2021 : Case report  USA 17,691,734

Edwardsiella tarda: A Classic Presentation of a Rare Fatal Infection, with Possible New Background Risk Fac...

DOI :10.12659/AJCR.934347

Am J Case Rep 2021; 22:e934347

06 Dec 2021 : Case report  Brazil 164,491

Lipedema Can Be Treated Non-Surgically: A Report of 5 Cases

DOI :10.12659/AJCR.934406

Am J Case Rep 2021; 22:e934406

21 Jun 2024 : Case report  China (mainland) 113,090

Intracranial Parasitic Fetus in a Living Infant: A Case Study with Surgical Intervention and Prognosis Anal...

DOI :10.12659/AJCR.944371

Am J Case Rep 2024; 25:e944371

0:00

07 Mar 2024 : Case report  USA 59,175

Neurocysticercosis Presenting as Migraine in the United States

DOI :10.12659/AJCR.943133

Am J Case Rep 2024; 25:e943133

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

American Journal of Case Reports eISSN: 1941-5923
American Journal of Case Reports eISSN: 1941-5923